3rd Quarter Results - Best ever

 | Source: Novo Nordisk A/S Novo Nordisk A/S

 
Strong growth in Earnings and Cash flow. Full-year EBITDA Outlook upgraded to DKK 15.0bn
Highlights 3Q 2003
  •            EBITDA was DKK 4.1bn, up 6.8%, driven by strict cost control
  •            Cash flow from operations was DKK 4.4bn, up 7.7%
  •            Net debt amounted to DKK 29.9bn, down 11.3% compared with the end of 2Q 2003
  •            Net income1 of DKK 782m, up 8.9%
  •            Good performance in TDC Mobile International and TDC Switzerland
  •            Outlook 2003 for EBITDA upgraded to DKK 15.0bn from DKK 14.8bn.
  •            Outlook 2003 for net revenues and net income reaffirmed2
    •  
     
     
    Balance Sheet at End of September:
     
    Consolidated balance sheets (USD '000)
    30.9.2003
    31.12.2002
    Change
     
     
     
     
     
     
     
     
    Fixed assets
    65,712
    32,836
    100%
    Current assets
    36,019
    38,589
    -7%
    Total assets
    101,731
    71,425
    42%
     
     
     
     
    Equity
    46,900
    39,861
    18%
    Long-term liabilities
    38,791
    14,627
    165%
    Current liabilities
    16,040
    16,937
    -5%
    Total equity and liabilities
    101,731
    71,425
    42%
     
     Download the report

    Pièces jointes

    Any name you want